Literature DB >> 16131422

Genetics of cerebral cavernous malformations.

Nicholas W Plummer1, Jon S Zawistowski, Douglas A Marchuk.   

Abstract

The past few years have seen rapid advances in our understanding of the genetics and molecular biology of cerebral cavernous malformations (CCM). This article summarizes the recent cloning of the CCM1, CCM2, and CCM3 genes, which are responsible for autosomal dominant CCM, and also describes current hypotheses for their roles in integrin and p38 mitogen-activated protein kinase- mediated regulation of angiogenesis. A mouse model of CCM has been generated by mutation of the Ccm1 gene, and it indicates a role for that protein in arterial development. Future studies will probably focus on integration of data from each of the three CCM genes into a single model of the pathogenesis of cavernous malformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131422     DOI: 10.1007/s11910-005-0063-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  43 in total

1.  Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.

Authors:  Mark T Uhlik; Amy N Abell; Nancy L Johnson; Weiyong Sun; Bruce D Cuevas; Katherine E Lobel-Rice; Eric A Horne; Mark L Dell'Acqua; Gary L Johnson
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

2.  Mekk3 is essential for early embryonic cardiovascular development.

Authors:  J Yang; M Boerm; M McCarty; C Bucana; I J Fidler; Y Zhuang; B Su
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

4.  Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene.

Authors:  T Sahoo; E Goenaga-Diaz; I G Serebriiskii; J W Thomas; E Kotova; J G Cuellar; J M Peloquin; E Golemis; F Beitinjaneh; E D Green; E W Johnson; D A Marchuk
Journal:  Genomics       Date:  2001-01-01       Impact factor: 5.736

5.  Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22.

Authors:  I Serebriiskii; J Estojak; G Sonoda; J R Testa; E A Golemis
Journal:  Oncogene       Date:  1997-08-28       Impact factor: 9.867

6.  Identification of eight novel 5'-exons in cerebral capillary malformation gene-1 (CCM1) encoding KRIT1.

Authors:  I Eerola; B McIntyre; M Vikkula
Journal:  Biochim Biophys Acta       Date:  2001-02-16

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

9.  KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.

Authors:  Ozlem Guzeloglu-Kayisli; Nduka M Amankulor; Jennifer Voorhees; Guven Luleci; Richard P Lifton; Murat Gunel
Journal:  Neurosurgery       Date:  2004-04       Impact factor: 4.654

10.  The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading.

Authors:  Simona Degani; Fiorella Balzac; Mara Brancaccio; Simona Guazzone; Saverio Francesco Retta; Lorenzo Silengo; Alessandra Eva; Guido Tarone
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

View more
  28 in total

Review 1.  Neurovascular development: The beginning of a beautiful friendship.

Authors:  Victoria L Bautch; Jennifer M James
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

Review 2.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

3.  Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation.

Authors:  Helong Zhao; Tara M Mleynek; Dean Y Li
Journal:  Nat Med       Date:  2016-09-07       Impact factor: 53.440

4.  Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.

Authors:  Asya L Borikova; Christopher F Dibble; Noah Sciaky; Christopher M Welch; Amy N Abell; Sompop Bencharit; Gary L Johnson
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 5.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

6.  High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort.

Authors:  M C Mabray; J Starcevich; J Hallstrom; M Robinson; M Bartlett; J Nelson; A Zafar; H Kim; L Morrison; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

7.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

8.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

9.  Lack of CCM1 induces hypersprouting and impairs response to flow.

Authors:  Tara M Mleynek; Aubrey C Chan; Michael Redd; Christopher C Gibson; Chadwick T Davis; Dallas S Shi; Tiehua Chen; Kandis L Carter; Jing Ling; Raquel Blanco; Holger Gerhardt; Kevin Whitehead; Dean Y Li
Journal:  Hum Mol Genet       Date:  2014-07-02       Impact factor: 6.150

10.  A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.

Authors:  Marilyn Goudreault; Lisa M D'Ambrosio; Michelle J Kean; Michael J Mullin; Brett G Larsen; Amy Sanchez; Sidharth Chaudhry; Ginny I Chen; Frank Sicheri; Alexey I Nesvizhskii; Ruedi Aebersold; Brian Raught; Anne-Claude Gingras
Journal:  Mol Cell Proteomics       Date:  2008-09-08       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.